8-(4-CHLOROPHENYL)-8-METHOXY-5-METHYL-8H-[1,4]-THIAZINO-[3,4-C]-[1,2,4]-OXADIAZOL-3-ONE
Compound with spectra: 1 NMR
![8-(4-CHLOROPHENYL)-8-METHOXY-5-METHYL-8H-[1,4]-THIAZINO-[3,4-C]-[1,2,4]-OXADIAZOL-3-ONE](/api/compound/90YvBBBBxIb.png?ph=true&h=300&w=458 "8-(4-CHLOROPHENYL)-8-METHOXY-5-METHYL-8H-[1,4]-THIAZINO-[3,4-C]-[1,2,4]-OXADIAZOL-3-ONE")
| SpectraBase Compound ID | 90YvBBBBxIb |
|---|---|
| InChI | InChI=1S/C13H11ClN2O3S/c1-8-7-20-13(18-2,9-3-5-10(14)6-4-9)11-15-19-12(17)16(8)11/h3-7H,1-2H3 |
| InChIKey | BBMGMJVPBGHYGA-UHFFFAOYSA-N |
| Mol Weight | 310.76 g/mol |
| Molecular Formula | C13H11ClN2O3S |
| Exact Mass | 310.017891 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
8-(p-Bromophenyl)-8-methoxy-5-methyl-8H-[1,4]-thiazino[3,4-c]-[1,2,4]-oxadiazol-3-one
Butanoic acid, heptafluoro-, 3,3-bis(chlorodifluoromethyl)tetrahydro-1-oxo-1H,3H-pyrrolo[1,2-c]oxa zol-6-yl ester
Pyridine-3-carboxamide, 5,6-dihydro-5-cyano-4-(3-fluorophenyl)-2-methyl-N-(2-methylphenyl)-6-thioxo-
DIETHYL-(1'S,2S,3S,4R,5S)-2'-(N-BENZYLOXYCARBONYL-3,4-ISOPROPYLIDENEDIOXY-5-METHYLPYRROLIDIN-2-YL)-1'-HYDROXYETHANEPHOSPHONATE
3-(6-Bromo-1,3-benzodioxol-5-yl)-1-methylbenzo[f]quinoline
2-Pyrrolidinone, 4-[1-[2-(3-methylphenoxy)ethyl]-1H-1,3-benzimidazol-2-yl]-1-[3-(trifluoromethyl)phenyl]-
acetamide, N-(4-fluorophenyl)-2-[[5-(4-fluorophenyl)-3,4-dihydro-4-oxo-3-(2-propenyl)thieno[2,3-d]pyrimidin-2-yl]thio]-
3'-O-Butyryl-adenosine
DPCPX
5,7,3',4'-TETRAHYDROXY-6-METHYL-FLAVANONOL
| Title | Journal or Book | Year |
|---|---|---|
| Cardiovascular Characterization of [1,4]Thiazino[3,4-c][1,2,4]oxadiazol-1-one Derivatives: Selective Myocardial Calcium Channel Modulators | Journal of Medicinal Chemistry | 2002 |